Use of the Internet in a multicenter study of chronic obstructive pulmonary disease in primary care. Pilot phase of the EFEMAP study;Utilización de Internet en un estudio multicéntrico sobre EPOC en atención primaria. Fase piloto del estudio EFEMAP

Archivos de Bronconeumologia

Volumn 38, Issue 9, 2002, Pages 427-430

  Miravitlles, M ^a   Llor, C ^b   Naberan, K ^c   Cots, J M ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b Sociedad Catalana de Medicina Familiar   (Spain)

^c Sociedad Catalana de Medicina de Familia   (Spain)

Author keywords

COPD; Exacerbations; Internet; Primary care; Treatment

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DRUG COST; DRUG UTILIZATION; ECONOMICS; FEMALE; HUMAN; INFORMATION PROCESSING; INTERNET; MALE; METHODOLOGY; MICROCOMPUTER; MIDDLE AGED; MULTICENTER STUDY; PATIENT ATTITUDE; PILOT STUDY; PRIMARY HEALTH CARE; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION; SMOKING; SPAIN; STATISTICS; TELEMEDICINE;

ACUTE DISEASE; ADULT; AGED; BACTERIAL INFECTIONS; COMPUTERS, HANDHELD; DATA COLLECTION; DRUG COSTS; DRUG UTILIZATION; FEMALE; HUMANS; INTERNET; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RESPIRATORY TRACT INFECTIONS; SMOKING; SPAIN; TELEMEDICINE;

EID: 0347368158     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(02)75256-3     Document Type: Article

References (13)

1. Sobradillo V, Miravitlles M, Gabriel R, Jiménez-Ruiz CA, Villasante C, Masa JF, et al. Geographical variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC multicentre epidemiological study. Chest 2000;118:981-9.
2. Miravitlles M, Mayordomo C, Artés M, Sánchez-Agudo L, Nicolau F, Segú JL. on behalf of the EOLO Group. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. Respir Med 1999;93:173-9.
3. Miravitlles M, Segú JI, Guerrero T, Gisbert R, Murio C (Grupo DAFNE). Estudio farmacoeconómico del tratamiento antibiótico de las agudizaciones de la bronquitis crónica en atención primaria. Aten Primaria 2000;25:153-9.
4. Miravitlles M, Murio C, Guerrero T, Gisbert R, on behalf of the DAFNE study group. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002;121:1449-55.
5. Barberà JA, Peces-Barba G, Agustí AGN, Izquierdo JL, Monsó E, Montemayor T, et al. Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 2001;37:297-316.
6. Anthonisen NR, Manfreda J, Warren PW, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
7. álvarez-Sala JL, Cimas E, Masa JF, Miravitlles M, Molina J, Naberan K, et al. Recomendaciones para la atención al paciente con enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 2001;37:269-78.
8. álvarez F, Bouza E, García-Rodríguez JA, Mayer MA, Mensa J, Monsó E, et al. Uso de antimicrobianos en la exacerbación de la enfermedad pulmonar obstructiva crónica. Rev Esp Quimioterap 2001;14:87-96.
9. Miravitlles M, Murio C, Guerrero T, Segú JL. Tratamiento de la bronquitis crónica y la EPOC en atención primaria. Arch Bronconeumol 1999;35:173-8.
10. Miravitlles M, Ros F, Cobos A, Kubin R, Tillotson G. The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis; a Spanish physician and patient experience. Int J Clin Pract 2001;55:437-41.
11. Miravitlles M, Murio C, Guerrero T, on behalf of the DAFNE Study Group. Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. A prospective multicenter study in the community. Eur Respir J 2001;17:928-33.
12. MacFarlane JT, Colville A, Guion A, MacFarlane RM, Rose DH. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet 1993;341:511-4.
13. Adams SG, Melo J, Luther M, Anzueto A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest 2000;117:1345-52.